Stay updated with breaking news from Cell Line. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BERLIN, Germany, January 11, 2022 / B3C newswire / -- ProBioGen today announced that Innovent Biologics, Inc. (1801.HK) has signed a multi-product license for ProBioGen's GlymaxX technology.Under this license agreement, Innovent receives non-exclusive rights to use the afucosylation technology GlymaxX for multiple c...
Researchers developed a human A549 lung epithelial cell-based model to probe SARS-CoV-2 replication.
Researchers from Germany, in their recent study published in the journal Cellular & Molecular Immunology, have evaluated the mutations in the S protein of one such SARS-CoV-2 strain, a Delta sublineage AY.4.2, which is currently expanding in the UK, and have found that it neither contains any potential for increased cell entry nor antibody escape.
Dublin, Jan. 07, 2022 (GLOBE NEWSWIRE) -- The "Technology Developments in Viral Vector Manufacturing for Cell and Gene Therapies" report has been added...
New research can confirm that while some of the response from monocytes to SARS-CoV-2 is generic to virus infection, most of it SARS-CoV-2 specific, especially proinflammatory responses.